NordiQC - Immunohistochemical Quality Control

2026

Oct

IHC Educational Seminar

Toronto, Canada - 3 Oct

Sep

NordiQC Seminar in Diagnostic Immunohistochemistry 2026

Aalborg, Denmark - 23–25 Sep

Jun

10th Course of Academy of Immunohistochemistry

Krakow - 22–24 Jun

May

NordiQC IHC Workshop in New Zealand

Auckland, New Zealand - 15–16 May

2025

Sep

NordiQC Seminar in Diagnostic Immunohistochemistry 2025

Aalborg, Denmark - 17–19 Sep

1-2 TJ Pre-analytical phase

1-3 TJ Analytical phase

1-4 SN Tissue tool box for controls

1-5 HH Lung cancer - IHC for diagnostic use

1-6 HLK Protocols and controls

2-1/2-2 RR The unknown primary tumour

2-3 TJ Protocols and controls

2-4 AVL Breast cancer - IHC for diagnostic use

2-5 HLK Protocols and controls

2-6 DVH Validation and verification process for IHC

2-7 SN The antibody graveyard

3-1 ISK Immunocytochemistry

3-2 KBA IHC in the time of molecular era

3-3 MB Multiplex staining

3-4 KBA Old tests - New challenges

1-7 SN Welcome

Programme

2024

Oct

NordiQC Seminar in Diagnostic Immunohistochemistry 2024

Aalborg, Denmark - 2–4 Oct

1-2 TJ Pre-analytical phase

1-3/1-4 MB Analytical phase I & 2

1-5 SN Tissue tool box for controls

2-1 RR The unknown primary tumour

2-2 TJ Antibody selection, protocols and controls

2-4 TJ antibody selection, protocols and controls

2-5 HH Lung cancer - IHC for diagnostic use

2-6 HLK Antibody selection, protocols and controls

2-7 SN The antibody graveyard

2-8/2-9 MB Multiplex staining

3-1 ISK Immunocytochemistry - overview, considerations and applications

3-2 HH IHC in the time of molecular era

3-3 AVL Breast cancer - IHC for diagnostic use

3-4 HLK Antibody selection, protocols and controls

3-5 SN IHC stainers - overview, pros and cons

Programme

Sep

dMMR and MSI Testing in Endometrial Cancer

Webinar - 24 Sep